(Q37980195)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Drugs and mitochondrial diseases: 40 queries and answers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Costanza Simoncini

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Daniele Orsucci

2

1 reference

ORCID Public Data File 2021

author name string

Michelangelo Mancuso

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Gabriele Siciliano

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

31 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

527-543

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

Mitochondrial respiratory-chain diseases

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Mitochondrial diseases: a nosological update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Prevalence of mitochondrial DNA disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Cell and animal models of mtDNA biology: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

A yeast-based assay identifies drugs active against human mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

adPEO mutations in ANT1 impair ADP-ATP translocation in muscle mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

The effect of OPA1 on mitochondrial Ca²⁺ signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Consequences of mutations in human DNA polymerase gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Canine spongiform leukoencephalomyelopathy is associated with a missense mutation in cytochrome b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Transmitochondrial mice as models for mitochondrial DNA-based diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1α gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Regulation of ubiquinone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

A randomized trial of coenzyme Q10 in mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

The uptake and distribution of coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Some observations upon biochemical causes of ataxia and a new disease entity ubiquinone, CoQ10 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Mutations in coenzyme Q10 biosynthetic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

21 January 2018

Human CoQ10 deficiencies

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Treatment of CoQ10 Deficient Fibroblasts with Ubiquinone, CoQ Analogs, and Vitamin C: Time- and Compound-Dependent Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Idebenone treatment in Leber's hereditary optic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

The effects of idebenone on mitochondrial bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Initial experience in the treatment of inherited mitochondrial disease with EPI-743.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Bioavailability enhancement of coenzyme Q10: an extensive review of patents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Water-soluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Mitochondrial targeting of quinones: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

A placebo-controlled crossover trial of creatine in mitochondrial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Effects of riboflavin in children with complex II deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Loss of a conserved tyrosine residue of cytochrome b induces reactive oxygen species production by cytochrome bc1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Cultured muscle cells display defects of mitochondrial myopathy ameliorated by anti-oxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Reactive oxygen species in skeletal muscle signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Safety of vitamins and minerals: controversies and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: a double-blind randomized crossover clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Endothelial dysfunction in MELAS improved by l-arginine supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

L-arginine improves the symptoms of strokelike episodes in MELAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Bezafibrate induced increase in mitochondrial electron transport chain complex IV activity in human astrocytoma cells: Implications for mitochondrial cytopathies and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

RETRACTED: Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

In vivo correction of COX deficiency by activation of the AMPK/PGC-1α axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Minocycline, a possible neuroprotective agent in Leber's hereditary optic neuropathy (LHON): studies of cybrid cells bearing 11,778 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Tetracycline delays ocular motility decline in chronic progressive external ophthalmoplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Ketogenic diet slows down mitochondrial myopathy progression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Mitochondrial diseases: therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Mitochondrial gene replacement in primate offspring and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Treatment of central nervous system manifestations in mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Management of mitochondrial stroke-like-episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Drugs interfering with mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Antimyoclonic effect of levetiracetam in MERRF syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2-024 and BIA 2-093.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Chronic impact of topiramate on acid-base balance and potassium in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Severe non-anion gap metabolic acidosis induced by topiramate: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Mutation analysis of mitochondrial 12S rRNA gene in Polish patients with non-syndromic and aminoglycoside-induced hearing loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Interaction of aminoglycosides with human mitochondrial 12S rRNA carrying the deafness-associated mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Severe lactic acidosis secondary to minocycline in a teenager with infectious mononucleosis and mitochondrial myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Impairment of mitochondrial function by minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Cellular and molecular mechanisms of metformin: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

The role of coenzyme Q10 in statin-associated myopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Muscle coenzyme Q10 level in statin-related myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Myotoxicity of lipid-lowering agents in a teenager with MELAS mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

The interactions of some commonly consumed drugs with mitochondrial adaptations to exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Iatrogenic and toxic myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Update on toxic myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Clinical implications of mitochondrial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Mitochondrial defects and anesthetic sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Malignant hyperthermia: pharmacology of triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

A modern approach to the treatment of mitochondrial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Oxidative stress is responsible for mitochondrial permeability transition induction by salicylate in liver mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Understanding lactic acidosis in paracetamol (acetaminophen) poisoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Acetylsalicylic acid and acetaminophen protect against MPP+-induced mitochondrial damage and superoxide anion generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Acetaminophen reduces mitochondrial dysfunction during early cerebral postischemic reperfusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Coenzyme Q10 and alpha-tocopherol protect against amitriptyline toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Metabolic acidosis in the critically ill: part 2. Causes and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Metabolic acidosis: pathophysiology, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Coenzyme Q10 and Neurological Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

The Interaction of Q Analogs, Particularly Hydroxydecyl Benzoquinone (Idebenone), with the Respiratory Complexes of Heart Mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

Safety, Tolerability, and Pharmacokinetics of High-Dose Idebenone in Patients With Friedreich Ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.657177

10.1517/14656566.2012.657177

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292617%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference